Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1570
Title: Balloon Aortic Valvuloplasty in the Transcatheter Valve Era: Single Centre Indications and Early Safety Data in a High Risk Population
Authors: Ford, Tom ;Nguyen, K.;Brassil, J.;Kushwaha, V.;Friedman, D.;Allan, R.;Pitney, M.;Jepson, N.
Affliation: Central Coast Local Health District
Gosford Hospital
Issue Date: May-2018
Source: 27(5):595-600
Journal title: Heart Lung and Circulation
Heart, Lung & Circulation
Department: Cardiology
Abstract: BACKGROUND: The introduction of transcatheter aortic valve implantation (TAVI) has generated a renewed interest in the techniques available to treat high-risk patients with severe aortic stenosis (AS). We report our single centre experience with balloon aortic valvuloplasty (BAV) focussing on indications, procedural success and 30-day outcomes. METHODS: We retrospectively reviewed all patients that underwent BAV procedures at our institution between August 2012 and August 2014. Procedural success and complications were adjudicated according to VARC-2 criteria. RESULTS: Fifty-one consecutive adult patients with severe symptomatic AS underwent a total of 55 BAV procedures. The patients had a mean age of 88+/-5.7 years and all had extensive comorbidities with a high surgical risk (mean logistic EuroSCORE of 25.22%+/-14.5%). Indications for BAV included palliation of symptoms n=42 (76%); bridge to definitive valve replacement (n=6, 11%); and evaluation of response (n=6, 11%). The procedure was completed in all patients with no intraprocedural deaths (within 24hours) and low 30-day mortality at 3.9% (n=2). Minor vascular complications occurred in 11.8% (n=6), whilst permanent pacemaker implantation was required in 5.8% (n=3). There were no cases of myocardial infarction, stroke, tamponade, severe aortic regurgitation or major vascular complications during 30-day follow-up. CONCLUSIONS: Balloon aortic valvuloplasty may be performed safely and effectively with high procedural success and low 30-day complications, even in a very high-risk and elderly cohort of patients in whom the role of TAVI is uncertain or inappropriate.
URI: https://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1570
DOI: 10.1016/j.hlc.2017.05.128
Pubmed: https://www.ncbi.nlm.nih.gov/pubmed/28688833
ISSN: 1443-9506
Publicaton type: Journal Article
Keywords: Cardiology
Cardiovascular Disease
Heart Disease
Appears in Collections:Cardiology

Show full item record

Page view(s)

54
checked on Jan 30, 2023

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.